NHS England has updated the Cancer Drugs Fund List to version 1.386.
https://updates.chemo.org.uk/news/CDFNews_1.386.html
Changes - 👇 🧵
NHS England has updated the Cancer Drugs Fund List to version 1.386.
https://updates.chemo.org.uk/news/CDFNews_1.386.html
Changes - 👇 🧵
4 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2026-02-12.html
Changes: nivolumab, amivantamab, alpelisib
4 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2026-02-12.html
Changes: nivolumab, amivantamab, alpelisib
4 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2026-02-09.html
Changes: amivantamab, abiraterone acetate, nivolumab
4 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2026-02-09.html
Changes: amivantamab, abiraterone acetate, nivolumab
16 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2026-02-05.html
Changes: paclitaxel albumin, entrectinib, vandetanib, Bosutinib, vedolizumab, upadacitinib hemihydrate,...
16 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2026-02-05.html
Changes: paclitaxel albumin, entrectinib, vandetanib, Bosutinib, vedolizumab, upadacitinib hemihydrate,...
13 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2026-02-02.html
Changes: fluorouracil, abemaciclib, selpercatinib, blinatumomab, epcoritamab, melphalan hydrochloride, ...
13 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2026-02-02.html
Changes: fluorouracil, abemaciclib, selpercatinib, blinatumomab, epcoritamab, melphalan hydrochloride, ...
5 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2026-01-29.html
Changes: talquetamab, encorafenib, plerixafor, fluorouracil
5 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2026-01-29.html
Changes: talquetamab, encorafenib, plerixafor, fluorouracil
NHS England has updated the Cancer Drugs Fund List to version 1.381.
https://updates.chemo.org.uk/news/CDFNews_1.381.html
Changes - 👇 🧵
NHS England has updated the Cancer Drugs Fund List to version 1.381.
https://updates.chemo.org.uk/news/CDFNews_1.381.html
Changes - 👇 🧵
NHS England has updated the Cancer Drugs Fund List to version 1.380.
https://updates.chemo.org.uk/news/CDFNews_1.380.html
Changes - 👇 🧵
NHS England has updated the Cancer Drugs Fund List to version 1.380.
https://updates.chemo.org.uk/news/CDFNews_1.380.html
Changes - 👇 🧵
8 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2026-01-26.html
Changes: belantamab mafodotin, mycophenolic acid as mycophenolate sodium, bacillus calmette-guerin, enco...
8 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2026-01-26.html
Changes: belantamab mafodotin, mycophenolic acid as mycophenolate sodium, bacillus calmette-guerin, enco...
18 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2026-01-22.html
Changes: atezolizumab, lorlatinib, Tarlatamab, bortezomib mannitol boronic ester, apremilast, nilotinib...
18 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2026-01-22.html
Changes: atezolizumab, lorlatinib, Tarlatamab, bortezomib mannitol boronic ester, apremilast, nilotinib...
7 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2026-01-19.html
Changes: brexucabtagene autoleucel, binimetinib, axicabtagene ciloleucel, atezolizumab
7 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2026-01-19.html
Changes: brexucabtagene autoleucel, binimetinib, axicabtagene ciloleucel, atezolizumab
5 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2026-01-15.html
Changes: Lisocabtagene maraleucel, pembrolizumab, ropeginterferon alfa-2b, brexucabtagene autoleucel, bi...
5 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2026-01-15.html
Changes: Lisocabtagene maraleucel, pembrolizumab, ropeginterferon alfa-2b, brexucabtagene autoleucel, bi...
6 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2026-01-12.html
Changes: abemaciclib, trastuzumab, belumosudil mesilate, Lisocabtagene maraleucel, pembrolizumab
6 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2026-01-12.html
Changes: abemaciclib, trastuzumab, belumosudil mesilate, Lisocabtagene maraleucel, pembrolizumab
8 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2026-01-08.html
Changes: obinutuzumab, sacituzumab govitecan, fedratinib dihydrochloride monohydrate, imlifidase, abemac...
8 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2026-01-08.html
Changes: obinutuzumab, sacituzumab govitecan, fedratinib dihydrochloride monohydrate, imlifidase, abemac...
6 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2026-01-05.html
Changes: mycophenolate mofetil, paclitaxel albumin, talquetamab, obinutuzumab, sacituzumab govitecan
6 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2026-01-05.html
Changes: mycophenolate mofetil, paclitaxel albumin, talquetamab, obinutuzumab, sacituzumab govitecan
31 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2026-01-01.html
Changes: cyclophosphamide, durvalumab, methotrexate, nivolumab, axicabtagene ciloleucel, methotrexate d...
31 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2026-01-01.html
Changes: cyclophosphamide, durvalumab, methotrexate, nivolumab, axicabtagene ciloleucel, methotrexate d...
11 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-12-22.html
Changes: trastuzumab, isatuximab, Mirvetuximab soravtansine, cisplatin, thiotepa, brexucabtagene autole...
11 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-12-22.html
Changes: trastuzumab, isatuximab, Mirvetuximab soravtansine, cisplatin, thiotepa, brexucabtagene autole...
9 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-12-18.html
Changes: trastuzumab, capivasertib, olaparib, pentostatin, pembrolizumab, ciltacabtagene autoleucel, Mir...
9 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-12-18.html
Changes: trastuzumab, capivasertib, olaparib, pentostatin, pembrolizumab, ciltacabtagene autoleucel, Mir...
8 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-12-15.html
Changes: daratumumab, acalabrutinib maleate, bevacizumab, Futibatinib, capivasertib, trastuzumab
8 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-12-15.html
Changes: daratumumab, acalabrutinib maleate, bevacizumab, Futibatinib, capivasertib, trastuzumab
5 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-12-11.html
Changes: osimertinib mesylate, cemiplimab, daratumumab, acalabrutinib maleate
5 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-12-11.html
Changes: osimertinib mesylate, cemiplimab, daratumumab, acalabrutinib maleate
5 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-12-08.html
Changes: imatinib mesilate, azathioprine, eculizumab, osimertinib mesylate, cemiplimab
5 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-12-08.html
Changes: imatinib mesilate, azathioprine, eculizumab, osimertinib mesylate, cemiplimab
6 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-12-04.html
Changes: dinutuximab beta, apremilast, imatinib mesilate, azathioprine
6 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-12-04.html
Changes: dinutuximab beta, apremilast, imatinib mesilate, azathioprine
7 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-12-01.html
Changes: afatinib dimaleate, ibrutinib, dinutuximab beta, apremilast
7 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-12-01.html
Changes: afatinib dimaleate, ibrutinib, dinutuximab beta, apremilast
4 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-11-27.html
Changes: ciltacabtagene autoleucel, afatinib dimaleate, ibrutinib
4 cancer treatment summary of product characteristics have been updated recently.
https://updates.chemo.org.uk/news/SPC_updates_2025-11-27.html
Changes: ciltacabtagene autoleucel, afatinib dimaleate, ibrutinib
NHS England has updated the Cancer Drugs Fund List to version 1.379.
https://updates.chemo.org.uk/news/CDFNews_1.379.html
Changes - 👇 🧵
NHS England has updated the Cancer Drugs Fund List to version 1.379.
https://updates.chemo.org.uk/news/CDFNews_1.379.html
Changes - 👇 🧵